Interleukin-6 (IL-6) - A molecule with both beneficial and destructive potentials

被引:425
作者
Gadient, RA
Otten, UH
机构
[1] VESALIANUM, DEPT PHYSIOL, CH-4051 BASEL, SWITZERLAND
[2] CALTECH, DIV BIOL, PASADENA, CA 91125 USA
关键词
D O I
10.1016/S0301-0082(97)00021-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Interleukin-6 (IL-6), a member of the neuropoietic cytokine family, initially was described in terms of its activities in the immune system and during inflammation. Accumulating evidence supports an essential role of IL-6 in the development, differentiation, regeneration and degeneration of neurons in the peripheral and central nervous system. Major sites of IL-6 synthesis are neurons and glial cells. Interleukin-6 functions are mediated by a specific receptor system composed of a binding site and a signal transducer. This receptor system can be modulated by a complex of IL-6 and soluble IL-6 receptor acting as agonist. The IL-6 can exert completely opposite actions on neurons, triggering either neuronal survival after injury or causing neuronal degeneration and cell death in disorders such as Alzheimer's disease. Development of selective IL-6 agonists and antagonists, as well as the usage of soluble IL-6 receptors. offers new possibilities for the treatment of neurodegenerative disorders. Furthermore, optimized genetic mouse models, including transgenic and knockout animals, should help to define the physiological and pathophysiological role of IL-6 in the nervous system. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:379 / 390
页数:12
相关论文
共 134 条
[1]   HUMAN ACOUSTIC NEUROMAS SECRETE INTERLEUKIN-6 IN CELL-CULTURE - POSSIBLE AUTOCRINE REGULATION OF CELL-PROLIFERATION [J].
ADAMS, EF ;
RAFFERTY, B ;
MOWER, J ;
WARD, H ;
PETERSEN, B ;
FAHLBUSCH, R .
NEUROSURGERY, 1994, 35 (03) :434-438
[2]   INTERLEUKIN-1-BETA ENHANCES SURVIVAL AND INTERLEUKIN-6 PROTECTS AGAINST MPP(+) NEUROTOXICITY IN CULTURES OF FETAL-RAT DOPAMINERGIC-NEURONS [J].
AKANEYA, Y ;
TAKAHASHI, M ;
HATANAKA, H .
EXPERIMENTAL NEUROLOGY, 1995, 136 (01) :44-52
[3]   PENETRATION OF INTERLEUKIN-6 ACROSS THE MURINE BLOOD-BRAIN-BARRIER [J].
BANKS, WA ;
KASTIN, AJ ;
GUTIERREZ, EG .
NEUROSCIENCE LETTERS, 1994, 179 (1-2) :53-56
[4]   INTERLEUKIN-6 AND ALPHA-2-MACROGLOBULIN INDICATE AN ACUTE-PHASE STATE IN ALZHEIMERS-DISEASE CORTICES [J].
BAUER, J ;
STRAUSS, S ;
SCHREITERGASSER, U ;
GANTER, U ;
SCHLEGEL, P ;
WITT, I ;
YOLK, B ;
BERGER, M .
FEBS LETTERS, 1991, 285 (01) :111-114
[5]   INDUCTION AND REGULATION OF INTERLEUKIN-6 GENE-EXPRESSION IN RAT ASTROCYTES [J].
BENVENISTE, EN ;
SPARACIO, SM ;
NORRIS, JG ;
GRENETT, HE ;
FULLER, GM .
JOURNAL OF NEUROIMMUNOLOGY, 1990, 30 (2-3) :201-212
[6]   Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients [J].
BlumDegen, D ;
Muller, T ;
Kuhn, W ;
Gerlach, M ;
Przuntek, H ;
Riederer, P .
NEUROSCIENCE LETTERS, 1995, 202 (1-2) :17-20
[7]  
BOLIN LM, 1995, J NEUROCHEM, V64, P850
[8]  
Bourde O, 1996, J NEUROIMMUNOL, V69, P135
[9]  
BRAKENHOFF JPJ, 1994, J BIOL CHEM, V269, P86
[10]   DELAYED-ONSET OF ALZHEIMERS-DISEASE WITH NONSTEROIDAL ANTIINFLAMMATORY AND HISTAMINE-H2 BLOCKING-DRUGS [J].
BREITNER, JCS ;
WELSH, KA ;
HELMS, MJ ;
GASKELL, PC ;
GAU, BA ;
ROSES, AD ;
PERICAKVANCE, MA ;
SAUNDERS, AM .
NEUROBIOLOGY OF AGING, 1995, 16 (04) :523-530